AIV Logo AIV Assistant

 Logo Ajanta Pharma Limited - AJANTPHARM.NS 2502.70 INR

P/E
35.10
EPS
73.45
Yield
1.09%
P/B
8.49
ROE
25.02
Beta
0.24
Target Price
3020.17 INR

2502.700 INR

2502.700 INR

Daily: -2.77%
Key Metrics

P/E: 35.10

EPS: 73.45

Book Value: 303.53

Price to Book: 8.49

Debt/Equity: 1.25

% Insiders: 66.402%

Growth

Revenue Growth: 0.11%

Earnings Growth: 0.12%

Estimates

Forward P/E: 25.96

Forward EPS: 99.28

Target Mean Price: 3020.17

Dividend

Dividend Yield: 1.09%

Annual dividends: 28.00 INR

Ex-Div. Date: Nov. 6, 2024

Payout: 38.08%

5y avg Yield: 0.81%

 Logo About Ajanta Pharma Limited - (AJANTPHARM.NS)

Country: India

Sector: Health Care

Website: http://www.ajantapharma.com

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Exchange Ticker
NSI (India) AJANTPHARM.NS
Dividend Yield

1.09% (5y avg: 0.81%)

Annual Dividends

28.00 INR

Next ex. div date

Nov. 6, 2024

Payout Ratio

38.08%

Historical Dividends
Year Total Dividends
2025 28.00 INR
2024 54.00 INR
2023 10.00 INR
2022 7.00 INR
2021 6.33 INR
2020 6.33 INR
2019 8.67 INR
2018 6.00 INR
2017 8.67 INR
2016 5.33 INR
2015 4.00 INR
2014 2.67 INR
2013 1.11 INR
2012 0.67 INR
2011 0.44 INR
2010 0.31 INR
2009 0.22 INR
2008 0.22 INR
2007 0.18 INR
2006 0.13 INR
2001 0.13 INR

Yearly aggregated dividends

Dividends

Ajanta Pharma Limited
Nov 27, 2024 Paid
Dividend
28.0 INR

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion